Evgen Pharma PLC (AIM:EVG), the clinical-stage drug development company, has announced the termination of its patent and know-how licence agreement with.
The following stocks are the leading risers and fallers on AIM in London on Wednesday.
AIM - WINNERS
Blancco Technology Group PLC, up 23% at 219.56 pence, 12-month range.
/PRNewswire/ Morphoceuticals Inc., a biotechnology company, announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial.